Tags

Type your tag names separated by a space and hit enter

Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice.
Eur J Pharmacol. 2012 May 05; 682(1-3):118-25.EJ

Abstract

Dietary flavonoids possess a multiplicity of neuroprotective actions in various central nervous pathophysiological conditions including depression. Ellagic acid is a polyphenolic compound that occurs in plants such as raspberries, nuts and eucalyptus species. The present study was designed to investigate the antidepressant-like effect of ellagic acid in mice using forced swimming test (FST) and tail suspension test (TST). The involvement of the monoaminergic and opioid systems in the antidepressant-like activity of ellagic acid was also studied. Our results showed that ellagic acid when administered acutely or chronically to mice (25, 50 and 100mg/kg, p.o.), produced a significant reduction in the duration of immobility, with a profile comparable to that of fluoxetine (20mg/kg, p.o.). However, ellagic acid treatment had no effect on the locomotor activity of mice when tested in actophotometer. The reduction in immobility time observed with ellagic acid treatment (50mg/kg, p.o.) was prevented by pretreatment with p-chlorophenylalanine (100mg/kg, i.p., a serotonin synthesis inhibitor), pindolol (10mg/kg, i.p., a β-adrenoceptors blocker/5HT(1A/1B) receptor antagonist), ketanserin (5mg/kg, i.p., a 5HT(2A/2B) receptor antagonist), ondansetron (1mg/kg, i.p., a 5HT(3) receptor antagonist), prazosin (1mg/kg, i.p., an α(1)-adrenoceptor antagonist) and yohimbine (1mg/kg, i.p., an α(2)-adrenoceptor antagonist), but not with naloxone (1mg/kg, i.p., an opioid receptor antagonist). Our results suggest that ellagic acid produced an antidepressant-like effect which was unrelated to its locomotor activity. Furthermore, this anti-immobility effect seems most likely to be mediated through an interaction with the monoaminergic system (serotonergic and noradrenergic systems) and not through the opioid system.

Authors+Show Affiliations

Department of Pharmacology, Pondicherry Institute of Medical Sciences (P.I.M.S.), Kalapet, Puducherry-605 014, India. drgirish@pimsmmm.netNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22387858

Citation

Girish, Chandrashekaran, et al. "Evidence for the Involvement of the Monoaminergic System, but Not the Opioid System in the Antidepressant-like Activity of Ellagic Acid in Mice." European Journal of Pharmacology, vol. 682, no. 1-3, 2012, pp. 118-25.
Girish C, Raj V, Arya J, et al. Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. Eur J Pharmacol. 2012;682(1-3):118-25.
Girish, C., Raj, V., Arya, J., & Balakrishnan, S. (2012). Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. European Journal of Pharmacology, 682(1-3), 118-25. https://doi.org/10.1016/j.ejphar.2012.02.034
Girish C, et al. Evidence for the Involvement of the Monoaminergic System, but Not the Opioid System in the Antidepressant-like Activity of Ellagic Acid in Mice. Eur J Pharmacol. 2012 May 5;682(1-3):118-25. PubMed PMID: 22387858.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. AU - Girish,Chandrashekaran, AU - Raj,Vishnu, AU - Arya,Jayasree, AU - Balakrishnan,Sadasivam, Y1 - 2012/02/24/ PY - 2012/01/30/received PY - 2012/02/11/revised PY - 2012/02/15/accepted PY - 2012/3/6/entrez PY - 2012/3/6/pubmed PY - 2012/7/18/medline SP - 118 EP - 25 JF - European journal of pharmacology JO - Eur J Pharmacol VL - 682 IS - 1-3 N2 - Dietary flavonoids possess a multiplicity of neuroprotective actions in various central nervous pathophysiological conditions including depression. Ellagic acid is a polyphenolic compound that occurs in plants such as raspberries, nuts and eucalyptus species. The present study was designed to investigate the antidepressant-like effect of ellagic acid in mice using forced swimming test (FST) and tail suspension test (TST). The involvement of the monoaminergic and opioid systems in the antidepressant-like activity of ellagic acid was also studied. Our results showed that ellagic acid when administered acutely or chronically to mice (25, 50 and 100mg/kg, p.o.), produced a significant reduction in the duration of immobility, with a profile comparable to that of fluoxetine (20mg/kg, p.o.). However, ellagic acid treatment had no effect on the locomotor activity of mice when tested in actophotometer. The reduction in immobility time observed with ellagic acid treatment (50mg/kg, p.o.) was prevented by pretreatment with p-chlorophenylalanine (100mg/kg, i.p., a serotonin synthesis inhibitor), pindolol (10mg/kg, i.p., a β-adrenoceptors blocker/5HT(1A/1B) receptor antagonist), ketanserin (5mg/kg, i.p., a 5HT(2A/2B) receptor antagonist), ondansetron (1mg/kg, i.p., a 5HT(3) receptor antagonist), prazosin (1mg/kg, i.p., an α(1)-adrenoceptor antagonist) and yohimbine (1mg/kg, i.p., an α(2)-adrenoceptor antagonist), but not with naloxone (1mg/kg, i.p., an opioid receptor antagonist). Our results suggest that ellagic acid produced an antidepressant-like effect which was unrelated to its locomotor activity. Furthermore, this anti-immobility effect seems most likely to be mediated through an interaction with the monoaminergic system (serotonergic and noradrenergic systems) and not through the opioid system. SN - 1879-0712 UR - https://www.unboundmedicine.com/medline/citation/22387858/Evidence_for_the_involvement_of_the_monoaminergic_system_but_not_the_opioid_system_in_the_antidepressant_like_activity_of_ellagic_acid_in_mice_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0014-2999(12)00170-7 DB - PRIME DP - Unbound Medicine ER -